A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00092872 |
Recruitment Status
:
Completed
First Posted
: September 28, 2004
Last Update Posted
: January 30, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Obesity | Drug: MK0557 | Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 359 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Investigator) |
Primary Purpose: | Treatment |
Official Title: | A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety, Tolerability, and Efficacy of MK0557 in Obese Patients |
Study Start Date : | November 2003 |
Actual Primary Completion Date : | February 2005 |
Actual Study Completion Date : | February 2005 |
- Body weight after 1 year of treatment. [ Time Frame: After 1 year of treatment ]
- Safety and tolerability. [ Time Frame: After 1 year of treatment ]
- Waist circumference; Blood pressure, body fat mass, biochemical markers (fasting plasma, lipid profile, fasting plasma glucose, leptin, insulin, insulin sensitivity); body weight after 2 years [ Time Frame: After 2 years ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Obese men and nonpregnant women between the ages of 18 and 65 years with a body mass index (height to weight ratio) as required by the study.
Exclusion Criteria:
- Patients with uncontrolled high blood pressure and/or diabetes mellitus (high blood sugar)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00092872
Study Director: | Medical Monitor | Merck Sharp & Dohme Corp. |
Publications of Results:
Responsible Party: | Merck Sharp & Dohme Corp. |
ClinicalTrials.gov Identifier: | NCT00092872 History of Changes |
Other Study ID Numbers: |
0557-012 MK0557-012 2004_031 |
First Posted: | September 28, 2004 Key Record Dates |
Last Update Posted: | January 30, 2015 |
Last Verified: | January 2015 |